IceCure Medical Ltd.
ICCM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001584371
No open-market purchases or sales by IceCure Medical Ltd. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $544.7K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding IceCure Medical Ltd. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 7 | 13 | +6 |
| Shares | 382.0K | 821.1K | +439.1K (+114.9%) |
| Value | $3.34M | $2.31M | −$1.02M (−30.7%) |
New holders (7)
Institutions that held IceCure Medical Ltd. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JPMorgan Chase & Co | 80,908 | $247.0K | 0.00% |
| Goldman Sachs Group Inc | 53,987 | $165.0K | 0.00% |
| Boothbay Fund Management, LLC | 20,000 | $61.0K | 0.00% |
| Personal Capital Advisors Corp | 14,956 | $45.0K | 0.00% |
| Susquehanna International Group Ltd. | 12,688 | $38.0K | 0.02% |
| Morgan Stanley | 998 | $3.00K | 0.00% |
| Credit Suisse AG | 55,996 | – | – |
Sold out (1)
Institutions that held IceCure Medical Ltd. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 100 | $1.00K |